A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

10.1097/01243894-200602000-00007 ◽

2006 ◽

Vol 1 (2) ◽

pp. 141-145 ◽

Cited By ~ 9

Author(s):

Yuh-Min Chen ◽

Reury-Perng Perng ◽

Chun-Ming Tsai ◽

Jacqueline Whang-Peng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

The Elderly ◽

Small Cell ◽

P2-246: Phase II randomized study of vinorelbine alone or plus cisplatin against Chemo-naïve Inoperable Non-small Cell Lung Cancer in the Elderly

10.1097/01.jto.0000283954.16518.77 ◽

2007 ◽

Vol 2 (8) ◽

pp. S670

Author(s):

Yuh-Min Chen ◽

Jen-Fu Shih ◽

Reury-Perng Perng ◽

Chun-Ming Tsai ◽

Jacqueline Whang-Peng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

The Elderly ◽

Small Cell ◽

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

10.1016/s1556-0864(15)31529-x ◽

2006 ◽

Vol 1 (2) ◽

pp. 141-145 ◽

Cited By ~ 7

Author(s):

Yuh-Min Chen ◽

Reury-Perng Perng ◽

Chun-Ming Tsai ◽

Jacqueline Whang-Peng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

The Elderly ◽

Small Cell ◽

Lonidamine plus Cyclophosphamide in the Treatment of Adanced Non-Small Cell Lung Cancer in the Elderly: A Phase II Study

Tumori Journal ◽

10.1177/030089169508100112 ◽

1995 ◽

Vol 81 (1) ◽

pp. 48-51 ◽

Cited By ~ 6

Author(s):

Franco Salvati ◽

Antonio Antilli ◽

Anna Rita Cruciani ◽

Alessandra Lombardi ◽

Luigi Mugnaini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

The Elderly ◽

Small Cell ◽

Lonidamine plus cyclophosphamide in the treatment of advanced non-small cell lung cancer in the elderly: A phase II study

Lung Cancer ◽

10.1016/0169-5002(95)90668-1 ◽

1995 ◽

Vol 13 (2) ◽

pp. 218

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

The Elderly ◽

Small Cell ◽

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

Oncology ◽

10.1159/000086992 ◽

2005 ◽

Vol 68 (4-6) ◽

pp. 485-492 ◽

Cited By ~ 11

Author(s):

Tony S.K. Mok ◽

Kwok Chi Lam ◽

Conrad Lee ◽

Li Zhang ◽

Herman Wong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Oral Etoposide ◽

Toxicity Profile ◽

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095 ◽

Cited By ~ 2

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Study Results

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Study Results

Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9004 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9004-9004 ◽

Cited By ~ 4

Author(s):

Daniel Richard Gomez ◽

George R. Blumenschein ◽

J. Jack Lee ◽

Mike Hernandez ◽

D. Ross Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Systemic Therapy ◽

Randomized Study ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

10.1097/jto.0b013e3181e8b3a3 ◽

2010 ◽

Vol 5 (10) ◽

pp. 1630-1636 ◽

Cited By ~ 122

Author(s):

John D. Hainsworth ◽

Cristina L. Cebotaru ◽

Vladimir Kanarev ◽

Tudor E. Ciuleanu ◽

Danail Damyanov ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Open Label